Loading...
AptarGroup, Inc.
ATR•NYSE
Healthcare
Medical - Instruments & Supplies
$160.99
$-0.83(-0.51%)
AptarGroup, Inc. (ATR) Financial Performance & Income Statement Overview
Review AptarGroup, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.74%
↑ 2.74%
Operating Income Growth
22.89%
↑ 22.89%
Net Income Growth
31.65%
↑ 31.65%
Operating Cash Flow Growth
11.85%
↑ 11.85%
Operating Margin
14.17%
↑ 14.17%
Gross Margin
36.41%
↑ 36.41%
Net Profit Margin
10.42%
↑ 10.42%
ROE
14.87%
↑ 14.87%
ROIC
15.17%
↑ 15.17%
AptarGroup, Inc. (ATR) Income Statement & Financial Overview
Review AptarGroup, Inc.'s (ATR) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $848.09M | $909.29M | $910.06M | $915.45M |
| Cost of Revenue | $518.67M | $558.51M | $632.41M | $647.11M |
| Gross Profit | $329.41M | $350.78M | $277.65M | $268.34M |
| Gross Profit Ratio | $0.39 | $0.39 | $0.31 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $149.33M | $152.78M |
| SG&A Expenses | $0.00 | $141.60M | $145.93M | $152.78M |
| Operating Expenses | $209.31M | $212.48M | $145.93M | $152.78M |
| Total Costs & Expenses | $727.98M | $767.13M | $778.34M | $799.88M |
| Interest Income | $3.08M | $3.02M | $3.10M | $2.90M |
| Interest Expense | $11.37M | $12.29M | $10.06M | $10.18M |
| Depreciation & Amortization | $67.45M | $67.02M | $64.97M | $64.35M |
| EBITDA | $194.89M | $210.44M | $193.28M | $178.84M |
| EBITDA Ratio | $0.23 | $0.23 | $0.21 | $0.20 |
| Operating Income | $120.11M | $138.30M | $131.72M | $115.56M |
| Operating Income Ratio | $0.14 | $0.15 | $0.14 | $0.13 |
| Other Income/Expenses (Net) | -$4.04M | -$7.17M | -$13.48M | -$11.24M |
| Income Before Tax | $116.07M | $131.13M | $118.25M | $104.32M |
| Income Before Tax Ratio | $0.14 | $0.14 | $0.13 | $0.11 |
| Income Tax Expense | $15.21M | $31.21M | $27.79M | $21.39M |
| Net Income | $100.94M | $100.04M | $90.45M | $83.10M |
| Net Income Ratio | $0.12 | $0.11 | $0.10 | $0.09 |
| EPS | $1.52 | $1.51 | $1.36 | $1.26 |
| Diluted EPS | $1.49 | $1.48 | $1.34 | $1.23 |
| Weighted Avg Shares Outstanding | $66.51M | $66.44M | $66.31M | $66.06M |
| Weighted Avg Shares Outstanding (Diluted) | $67.92M | $67.72M | $67.58M | $67.43M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan